[1]吴一鸣 杨震 秦利.细胞因子与妊娠糖尿病的关系[J].国际内分泌代谢杂志,2018,38(01):59-62.[doi:10.3760/cma.j.issn.1673-4157.2018.01.016]
　Wu Yiming,Yang Zhen,Qin Li.Relationship between cytokines and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(01):59-62.[doi:10.3760/cma.j.issn.1673-4157.2018.01.016]
点击复制

细胞因子与妊娠糖尿病的关系()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
38
期数:
2018年01期
页码:
59-62
栏目:
综述
出版日期:
2018-01-20

文章信息/Info

Title:
Relationship between cytokines and gestational diabetes mellitus
作者:
吴一鸣 杨震 秦利
200092 上海交通大学医学院附属新华医院内分泌科
Author(s):
Wu Yiming; Yang Zhen; Qin Li
.Department of Endocrinology,Xinhua Hospital Affiliated Shanghai Jiaotong University School of Medicine,Shanghai 200092, China
关键词:
细胞因子;  妊娠糖尿病;  胰岛素抵抗
Keywords:
Cytokines;  Gestational diabetes mellitus;  Insulin resistance
DOI:
10.3760/cma.j.issn.1673-4157.2018.01.016
摘要:
妊娠糖尿病(GDM)的发病机制尚未明确,可能与胰岛素抵抗(IR)和胰岛β细胞功能受损有关。研究发现,胎球蛋白A、脂肪酸结合蛋白4、成纤维细胞生长因子21可能通过影响胰岛素信号通路,改变胰岛素敏感性; 视黄醇结合蛋白4通过炎性反应机制导致IR; Wnt诱导分泌蛋白-1、分泌型卷曲相关蛋白5则作用于Wnt信号通路,参与调节炎性反应; 鸢尾素可促进脂肪细胞燃烧; 促代谢因子通过调节血脂代谢间接调节血糖。总之,细胞因子作用机制复杂,其分泌紊乱与GDM的发生、发展密切相关。
Abstract:
The pathophysiology of gestational diabetes mellitus(GDM)remains incompletely understood,insulin resistance and islet β cells dysfunction may involved in the pathogenesis of GDM.Studies indicated that fetuin A,fibroblast growth factor 21 and fatty acid-binding protein 4 might influence insulin sensitivity by effecting insulin signal pathway.Inflammation may involve in the mechanisms for retinol-binding protein 4 induced insulin resistance.Wnt-induced secreted protein-1 and secreted frizzle-related protein-5 play a role in inflammation through regulating Wnt signal pathway.Meanwhile,irisin can promote the burning of fat cells.Betatrophin may adjust glucose metabolism indirectly by regulating lipids metabolism.In conclusion,the mechanisms of cytokines are complex, the disorder of secretion is closely related to the occurrence and development of GDM.

参考文献/References:


[1] Iyidir OT,Degertekin CK,Yilmaz BA,et al. Serum levels of fetuin A are increased in women with gestational diabetes mellitus[J].Arch Gynecol Obstet,2015,291(4):933-937.DOI:10.1007/s00404-014-3490-3.
[2] Kralisch S,Hoffmann A,Lössner U,et al.Regulation of the novel adipokines/hepatokines fetuin A and fetuin B in gestational diabetes mellitus[J].Metabolism,2017,68:88-94.DOI:10.1016/j.metabol.2016.11.017.
[3] Meex RC,Hoy AJ,Morris A,et al. Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism[J].Cell Metab,2015,22(6):1078-1089.DOI:10.1016/j.cmet.2015.09.023.
[4] Li SM,Wang WF,Zhou LH,et al.Fibroblast growth factor 21 expressions in white blood cells and sera of patients with gestational diabetes mellitus during gestation and postpartum[J].Endocrine,2015,48(2):519-527.DOI:10.1007/s12020-014-0309-8.
[5] Megia A,Gil-Lluis P,Näf S,et al.Cord blood FGF21 in gestational diabetes and its relationship with postnatal growth[J].Acta Diabetol,2015,52(4):693-700.DOI:10.1007/s00592-014-0705-9.
[6] Dekker Nitert M,Barrett HL,Kubala MH,et al.Increased placental expression of fibroblast growth factor 21 in gestational diabetes mellitus[J].J Clin Endocrinol Metab,2014,99(4):E591-E598.DOI:10.1210/jc.2013-2581.
[7] Sánchez-Infantes D,Gallego-Escuredo JM,Díaz M,et al.Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations[J].Int J Obes(Lond),2015,39(5):742-746.DOI:10.1038/ijo.2015.2.
[8] Lin Z,Tian H,Lam KS,et al.Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice[J].Cell Metab,2013,17(5):779-789.DOI:10.1016/j.cmet.2013.04.005.
[9] Guo Q,Xu L,Liu J,et al.Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice[J].Exp Biol Med(Maywood),2017,242(4):441-447.DOI:10.1177/1535370216677354.
[10] Sun X,Zhang Z,Ning H,et al.Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: a randomized and double-blind trial[J].Metab Brain Dis,2017,32(3):773-778.DOI:10.1007/s11011-017-9958-7.
[11] Moraes-Vieira PM,Castoldi A,Aryal P,et al.Antigen presentation and T-cell activation are critical for RBP4-induced insulin resistance[J].Diabetes,2016,65(5):1317-1327.DOI:10.2337/db15-1696.
[12] Chen Y,Lv P,Du M,et al.Increased retinol-free RBP4 contributes to insulin resistance in gestational diabetes mellitus[J].Arch Gynecol Obstet,2017,296(1):53-61.DOI:10.1007/s00404-017-4378-9.
[13] Zhang Y,Zhang HH,Lu JH,et al.Changes in serum adipocyte fatty acid-binding protein in women with gestational diabetes mellitus and normal pregnant women during mid- and late pregnancy[J].J Diabetes Investig,2016,7(5):797-804. DOI:10.1111/jdi.12484.
[14] Ning H,Tao H,Weng Z,et al.Plasma fatty acid-binding protein 4(FABP4)as a novel biomarker to predict gestational diabetes mellitus[J].Acta Diabetol,2016,53(6):891-898.DOI:10.1007/s00592-016-0867-8.
[15] Sahin Ersoy G,Altun Ensari T,Subas S,et al.WISP1 is a novel adipokine linked to metabolic parameters in gestational diabetes mellitus[J].J Matern Fetal Neonatal Med,2017,30(8):942-946.DOI:10.1080/14767058.2016.1192118.
[16] Oztas E,Ozler S,Ersoy E,et al.Prediction of gestational diabetes mellitus by first trimester serum secreted frizzle-related protein-5 levels[J].J Matern Fetal Neonatal Med,2016,29(9):1515-1519.DOI:10.3109/14767058.2015.1052399.
[17] Erol O,Ellidagˇ HY,Aylk H,et al.Evaluation of circulating betatrophin levels in gestational diabetes mellitus[J].Gynecol Endocrinol,2015,31(8):652-656.DOI:10.3109/09513590.2015.1056142.
[18] Xie X,Gao H,Wu S,et al.Increased cord blood betatrophin levels in the offspring of mothers with gestational diabetes[J].PLoS One,2016,11(5):e0155646.DOI:10.1371/journal.pone.0155646.
[19] Quagliarini F,Wang Y,Kozlitina J,et al.Atypical angiopoietin-like protein that regulates ANGPTL3[J].Proc Natl Acad Sci U S A,2012,109(48):19751-19756.DOI:10.1073/pnas.121755 2109.
[20] Erol O,Erkal N,Ellidagˇ HY,et al.Irisin as an early marker for predicting gestational diabetes mellitus: a prospective study[J].J Matern Fetal Neonatal Med,2016,29(22):3590-3595.DOI:10.3109/14767058.2016.1142967.
[21] Usluogˇullari B,Usluogullari CA,Balkan F,et al.Role of serum levels of irisin and oxidative stress markers in pregnant women with and without gestational diabetes[J].Gynecol Endocrinol,2017,33(5):405-407.DOI:10.1080/09513590.2017.1284789.
[22] Zhang Y,Li R,Meng Y,et al.Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling[J].Diabetes,2014,63(2):514-525.DOI:10.2337/db13-1106.

相似文献/References:

[1]袁扬,孙子林.PANDER与β细胞凋亡[J].国际内分泌代谢杂志,2007,(04):253.
[2]蒋真斌,孙嘉.白细胞介素-17与骨质疏松[J].国际内分泌代谢杂志,2014,(02):103.[doi:10.3760/cma.j.issn.1673-4157.2014.02.009]
　Jiang Zhenbin*,Sun Jia.Interleukin-17 and osteoporosis[J].International Journal of Endocrinology and Metabolism,2014,(01):103.[doi:10.3760/cma.j.issn.1673-4157.2014.02.009]
[3]林戎,沈忱,黄昭穗.瘦素与妊娠糖尿病患者胰岛素抵抗及胎儿 发育的相关性[J].国际内分泌代谢杂志,2017,37(06):367.
　Lin Rong,Shen Chen,Huang Zhaosui..Relationship between leptin and insulin resistance, fetal growth and development in patients with gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(01):367.
[4]周晓聪 张晓黎.益生菌与妊娠糖尿病的相关性[J].国际内分泌代谢杂志,2018,38(05):313.[doi:10.3760/cma.j.issn.1673-4157.2018.05.007]
　Zhou Xiaocong,Zhang Xiaoli.Relationship between probiotics and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(01):313.[doi:10.3760/cma.j.issn.1673-4157.2018.05.007]
[5]孙树凯 翟玉娥 田清武 赵鹏 申井利 翟木绪.雌激素受体基因多态性与妊娠糖尿病的 相关性研究[J].国际内分泌代谢杂志,2018,38(06):361.[doi:10.3760/cma.j.issn.1673-4157.2018.06.001]
　Sun Shukai*,Zhai Yu'e,Tian Qingwu,et al.Correlation between polymorphism of estrogen receptor gene and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(01):361.[doi:10.3760/cma.j.issn.1673-4157.2018.06.001]
[6]王香青 马振军 孔方方.外泌体与妊娠糖尿病[J].国际内分泌代谢杂志,2019,39(03):194.[doi:10.3760/cma.j.issn.1673-4157.2019.03.012]
　Wang Xiangqing,Ma Zhenjun,Kong Fangfang.Exosomes and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2019,39(01):194.[doi:10.3760/cma.j.issn.1673-4157.2019.03.012]
[7]郑妙艳 石文琦 张美琳 单春艳.microRNA作为妊娠糖尿病标志物的研究进展[J].国际内分泌代谢杂志,2019,39(04):272.[doi:10.3760/cma.j.issn.1673-4157.2019.04.014]
　Zheng Miaoyan,Shi Wenqi,Zhang Meilin,et al.Perspectives in microRNA as biomarkers of gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2019,39(01):272.[doi:10.3760/cma.j.issn.1673-4157.2019.04.014]
[8]苏亚峰 相萍萍 陈国芳 刘超.低升糖指数饮食与糖尿病血糖及血脂控制的关系[J].国际内分泌代谢杂志,2020,40(01):31.[doi:10.3760/cma.j.issn.1673-4157.2020.01.007]
　Su Yafeng,Xiang Pingping,Chen Guofang,et al.Relationship between low glycemic index diet and blood glucose, blood lipid control in diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2020,40(01):31.[doi:10.3760/cma.j.issn.1673-4157.2020.01.007]
[9]徐昳文,周红文.妊娠期葡萄糖激酶基因突变导致的青少年发病的成人型糖尿病研究进展[J].国际内分泌代谢杂志,2021,41(05):418.[doi:10.3760/cma.j.cn121383-20210603-06005]
　Xu Yiwen,Zhou Hongwen..Recent progress in glucokinase-maturity-onset diabetes of the young in pregnancy[J].International Journal of Endocrinology and Metabolism,2021,41(01):418.[doi:10.3760/cma.j.cn121383-20210603-06005]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81370953); 上海市卫生系统优秀人才培养计划(XYQ2013098)
通信作者:秦利,Email:qinli@medmail.com.cn
更新日期/Last Update: 2018-01-30